ASCRS Glaucoma Day | ASCRS
May 05, 2023
San Diego, CA

ASCRS Glaucoma Day

Attend this one-day meeting to expand your glaucoma treatment and surgical knowledge. This program is a comprehensive overview of all of the advancements in glaucoma management to improve your patient outcomes.

ASCRS Glaucoma Day 2023

Friday, May 5, 2023
8:00 AM – 3:45 PM (PST)
San Diego Convention Center | Room: 6CF

Description: Expand your knowledge of glaucoma treatment options with cutting-edge guidance to influence your practice and improve patient outcomes. Acclaimed speakers, real-world case studies, debates, videos, and the latest surgical techniques and clinical advances make ASCRS Glaucoma this year’s premier glaucoma event.

Program Chairs

Leon Herndon

Leon Herndon, MD


Nate Radcliffe, MD


Apr 21, 2022

8:00 – 9:00 a.m.
Session I: ASCRS/AGS Joint Symposium

Refractive Considerations in Glaucoma Patients - Optimizing Outcomes and Quality of Life
Co-Moderators: Sameh Mosead, MD & Craig J. Chaya, MD
Panel: Kavitha R Sivaraman, MD, Austin R Fox, MD, Christine L Larsen, MD, Elizabeth Martin, MD

8:00 – 8:04 A.M. (4 min)
Welcome Remarks
Leon Herndon, MD; Nathan Radcliffe, MD
8:05 – 8:12 A.M. (7 min)
Refractive impact of topical meds
Kavitha R Sivaraman, MD
8:13 – 8:18 A.M. (5 min)
Panel Discussion
8:19 – 8:26 A.M. (7 min)
Contact lens management after glaucoma surgery
Austin R Fox, MD
8:27 – 8:32 A.M. (6 min)
Panel Discussion
8:33 – 8:40 A.M. (7 min)
Advanced Technology IOLs, femto laser and the glaucoma patient
Christine L Larsen, MD
8:41 – 8:46 A.M. (5 min)
Panel Discussion
8:47 – 8:54 A.M. (7 min)
Refractive goals in combined or sequential phaco/glaucoma surgery
Elizabeth Martin, MD
8:55 – 9:00 A.M. (5 min)
Panel Discussion
9:00 – 10:15 a.m.
Session II: Glaukomtecken

This session will highlight how to correctly employ a variety of OCT approaches in clinical practice. It will also cover fundamental and modern/advanced concepts in visual field interpretation.
Co-Moderators: Arsham Sheybani, MD & Nathan Radcliffe, MD
Panel: Monica Ertel, MD, Sanjay Asrani, MD, Lauren Blieden, MD, Jason Bacharach, MD, Robert Weinreb, MD

Part 1: Tried and True Diagnostics
9:00 – 9:08 A.M. (8 min)
Visual field/visual field artifact
Monica Ertel, MD
9:09 – 9:17 A.M. (8 min)
Sanjay Asrani, MD
9:18 – 9:26 A.M. (8 min)
Anterior Segment OCT
Lauren Blieden, MD
9:27 – 9:42 A.M. (15 min)
Panel Discussion/Q&A
Part 2: Stepping up your game
9:43 – 9:51 A.M. (8 min)
Next level visual field detection techniques
Jason Bacharach, MD
9:52 – 10:00 A.M. (8 min)
Robert Weinreb, MD
10:01 – 10:15 A.M. (14 min)
Panel Discussion/Q&A
10:45 a.m. – 12:00 p.m.
Session III: Medications, Lasers, & Lifestyle

Strategies to treat glaucoma from lifestyle modifications, medication use, to laser therapy. It will also focus on the well-being of our patients and surgeons to diminish risks over time.
Moderator: Deborah Ristvedt, DO
Panel: Brian Shafer, MD, Sarah Van Tassel, MD, Andrew Camp, MD, Brian Francis, MD, Yasemin Sozeri, MD, Simon Law, MD, Deepinder Dhaliwal, MD

Part 1: Medications
10:45 - 10:53 A.M. (8 min)
Rookies, Veterans, and Recruits: Update on meds, sustained drug delivery, and what is coming down the pipeline
Brian Shafer, MD
10:54 - 11:02 A.M. (8 min)
STRATEGIC THINKING: incorporating medications after MIGS
Sarah Van Tassel, MD
11:03 - 11:11 A.M. (8 min)
Clear shot: Optimizing the surface in glaucoma patients
Andrew Camp, MD
Part 2: Lasers
11:12 - 11:20 A.M. (8 mins)
Laser focus: How to successfully use micropulse and ECP in practice
Brian Francis, MD
11:21 - 11:29 A.M. (8 mins)
Under the Lights: SLT as first line, bilateral treatment, and update on DSLT
Yasemin Sozeri, MD
Part 3: Lifestyle
11:30 - 11:38 A.M. (8 mins)
EAT, SLEEP, BREATHE GLAUCOMA: How nutrition, mental health, and positioning effect glaucoma
Simon Law, MD
11:39 - 11:47 A.M. (8 mins)
Deepinder Dhaliwal, MD
11:48 - 12:00 P.M. (12 mins)
Panel Discussion/Q&A
1:00 – 2:15 P.M. (75 min)
Session IV: Surgical Spotlight

Co-Moderators: Davinder Grover, MD, MPH & David Crandall, MD
Panel: Kuldev Singh, MD, MPH, Mary Qiu, MD, Sahar Bedrood, MD, PhD, Robert Noecker, MD, MBA, Inder Paul Singh, MD, Paul Harasymowycz, FRCSC, MD

What procedure would you have? Moderators Present 2 cases and panelists will use their time to talk through what they would have done if it were them.
1:00 – 1:04 P.M. (4 min)
Moderators Present Mild and Moderate Cases
Davinder Grover, MD, MPH & David Crandall, MD
1:04 – 1:12 P.M. (8 min)
Talk #1
Kuldev Singh, MD, MPH
1:13 – 1:21 P.M. (8 min)
Talk #2
Mary Qiu, MD
1:22 – 1:30 P.M. (8 min)
Talk #3
Sahar Bedrood, MD, PhD
1:31 – 1:36 P.M. (5 min)
Panel Discussion/Q&A
Red Flags/When to refere
1:36 – 1:44 P.M. (8 min)
Managing a Trab that someone else did
Robert Noecker, MD, MBA
1:45 – 1:53 P.M. (8 min)
How do you manage Tube patients?
Inder Paul Singh, MD
1:54 – 2:02 P.M. (8 min)
Stent repositioning – when to refer after angle surgery
Paul Harasymowycz, FRCSC, MD
2:02 – 2:09 P.M. (7 min)
Panel Discussion/Q&A
2:45 – 3:15 P.M. (30 min)
Session VI: Stephen A. Obstbaum, MD, Honored Lecture

Speaker: Ike Ahmed, MD

3:10 – 3:15 P.M. (5 min)
Award Presentation
Leon Herndon, MD
2:45 – 2:50 P.M. (5 min)
Nathan Radcliffe, MD
2:50 – 3:10 P.M. (20 min)
Ike Ahmed, MD
3:15 – 3:45 P.M. (30 min)
Session VII: 13th Annual Video Session: Complications and a Reay of Hope

Moderator: Manjool Shah, MD
Panel: Leon Herndon, MD, Ang Li, MD, Mary Qiu, MD, Ari Leshno, MD, Aakriti Shukla, MD

3:15 - 3:17 P.M. (2 min)
Introductory Remarks
Manjool Shah, MD
3:17 - 3:21 P.M. (4 min)
Complicated Case Video #1
Leon Herndon, MD
3:22 - 3:26 P.M. (4 min)
Complicated Case Video #2
Ang Li, MD
3:27 - 3:31 P.M. (4 min)
Complicated Case Video #3
Mary Qiu, MD
3:32 - 3:36 P.M. (4 min)
Complicated Case Video #4
Ari Leshno, MD & Aakriti Shukla, MD
3:37 - 3:40 P.M. (3 min)
Audience Vote: Best Video
3:40 - 3:42 P.M. (2 min)
Award Presentation
Manjool Shah, MD
3:42 - 3:45 P.M. (3 min)
Closing Remarks
Leon Herndon, MD; Nathan Radcliffe, MD


Accreditation Statement

The American Society of Cataract and Refractive Surgery is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. ASCRS takes responsibility for the content, quality and scientific integrity of the CME activity.

Designation Statement

The American Society of Cataract and Refractive Surgery designates this live activity for a maximum of 6.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

All CME activities approved for AMA PRA Category 1 CreditsTM are valid for recognition by the European Accreditation Council for Continuing Medical Education (EACCME). Physicians not licensed in the U.S. who participate in this CME activity are eligible for AMA PRA Category 1 CreditsTM.

Target Audience

Practicing ophthalmologists who care for patients with glaucoma-related conditions.

Educational Objectives

  • Effectively evaluate current and new diagnostic testing modalities to assist in the early diagnosis of the glaucoma patient and glaucoma suspect as well as disease progression
  • Make treatment decisions using evidence-based recommendations regarding the use of medical and laser therapies for the treatment of glaucoma
  • Evaluate best surgical options and considerations for patients with complex, pre-existing, and advanced glaucoma, with or without cataract
  • Discuss recent and emerging microinvasive glaucoma surgical (MIGS) options
  • Integrate pearls to improve glaucoma surgical outcomes
  • Implement strategies to manage glaucoma surgical challenges

Claim CME/CE Credits

Attendees can evaluate the 2023 ASCRS Glaucoma Day Program online through the Claim CME/CE Credit Stations. When the evaluation is complete, a copy of the certificate for continuing education credits/hours for that day can be printed. If attendees do not complete the evaluation during the meeting, they will have the opportunity to complete them at home.

Notice About Off-Label Use Presentations

The ASCRS Annual Meeting may include presentations on drugs or devices or uses of drugs or devices that may not have been approved by the Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he or she wishes to use in clinical practice.

ASCRS is committed to the free exchange of medical education. Inclusion of any presentation in this program, including presentations of off-label uses, does not imply an endorsement by ASCRS of the uses, products or techniques presented.